Ts03 Inc (TSTIF) 1.7477 $TSTIF
TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update
PR Newswire - Wed Jun 01, 4:00PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to a previously announced request for additional information by the U.S. Food and Drug Administration (the FDA) and that it has substantially completed its improvements to its manufacturing facility in Québec.
TOS.TO: 2.23 (-0.02)
Canadian Journal of Infection Control to Publish Paper on TSO3's STERIZONE® VP4 Sterilizer
PR Newswire - Wed May 18, 1:36PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that a peer-reviewed paper describing the Company's STERIZONE® VP4 Sterilizer has been accepted for publication in the Canadian Journal of Infection Control (CJIC). The paper entitled "The First Dual-Sterilant Low-Temperature Sterilization System" will appear in an upcoming issue of the publication.
TOS.TO: 2.23 (-0.02)
TSO3 announces the Results of the Votes from its Annual and Special Meeting of the Shareholders
PR Newswire - Thu May 05, 3:02PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated March 22, 2016, were elected as directors of TSO3 Inc. In addition, all other proposals submitted by management were approved.
TOS.TO: 2.23 (-0.02)
TSO3 Reports Record First Quarter 2016 Results
PR Newswire - Wed May 04, 5:30AM CDT
Commercial Rollout Drives Revenues of US$3.1 Million and Gross Profit of US$1.1 Million
TOS.TO: 2.23 (-0.02)
TSO3 to Report First Quarter 2016 Results and Hold Annual General and Special Meeting of Shareholders on Wednesday, May 4, 2016
PR Newswire - Tue Apr 26, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will report its first quarter 2016 financial results ended March 31, 2016 via press release on Wednesday, May 4, 2016 before the market opens.
TOS.TO: 2.23 (-0.02)
TSO3 to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2016
PR Newswire - Mon Apr 18, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at Bloom Burton & Co. Healthcare Investor Conference being held on May 2-3, 2016 at the Sheraton Centre Toronto Hotel in Toronto, Ontario.
TOS.TO: 2.23 (-0.02)
TSO3 Receives FDA 510(k) Clearance for Universal Design of STERIZONE® VP4 Sterilizer
PR Newswire - Mon Mar 28, 6:00AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a universal design of its STERIZONE® VP4 Sterilizer.
TOS.TO: 2.23 (-0.02)
TSO3 Reports Fourth Quarter and Full Year 2015 Results
PR Newswire - Wed Mar 23, 6:00AM CDT
Orders Received in 2015 Drive 2016 Commercial Rollout of STERIZONE® VP4 Sterilizer
TOS.TO: 2.23 (-0.02)
TSO3 Provides Update on Extended U.S. Claims Filed for Breakthrough Medical Device Sterilizer
PR Newswire - Mon Mar 14, 6:00AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has received feedback from the U.S. regulators regarding the company's recent application to extend claims for the STERIZONE® VP4 Sterilizer.
TOS.TO: 2.23 (-0.02)
TSO3 to Present at the 28th Annual ROTH Conference on March 16, 2016
PR Newswire - Thu Mar 10, 6:30AM CST
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at the 28th Annual ROTH Capital Partners Conference, which is being held on March 14-16, 2016 at The Ritz-Carlton, Laguna Niguel in Dana Point, California.
TOS.TO: 2.23 (-0.02)
TSO3 Appoints Harold R. Tessman as COO
PR Newswire - Wed Jan 27, 5:30AM CST
TSO3 Inc. (TSX: TOS), a leader in low-temperature medical device sterilization, has appointed Harold R. Tessman to the new position of chief operating officer.
TOS.TO: 2.23 (-0.02)
TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
PR Newswire - Tue Dec 22, 6:00AM CST
Company Submits Required Documentation Seeking Clearance to Extend Sterilization Claims to Include up to Eight Channels in a Single Device for its STERIZONE® VP4 Sterilizer - an Industry First
TOS.TO: 2.23 (-0.02)
TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
PR Newswire - Mon Dec 21, 3:37PM CST
Company Notifies Suppliers and Accelerates Workforce Recruitment in Canada and the United States
TOS.TO: 2.23 (-0.02)
TSO3 Appoints Glen Kayll as Chief Financial Officer
PR Newswire - Fri Dec 18, 6:00AM CST
Seasoned Public Company CFO With Financial and Cross Border Listing Experience to Join Management Team
TOS.TO: 2.23 (-0.02)
TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
PR Newswire - Thu Dec 17, 6:00AM CST
STERIZONE® VP4 Sterilizer Validated to Sterilize Complex, Multi-Channel Endoscopic Devices
TOS.TO: 2.23 (-0.02)
TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
PR Newswire - Wed Nov 25, 10:40AM CST
US$7.5 Million Up-Front License Fees and Performance Minimums Highlights of Agreement
TOS.TO: 2.23 (-0.02)
IIROC Trade Halt - TSO3 Inc.
Newsfile Corp - Wed Nov 25, 8:36AM CST
The following issues have been halted by IIROC:
TSO3 Appoints Steve West to Board of Directors
PR Newswire - Tue Nov 10, 9:14AM CST
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has appointed Steve West to the Company's board of directors.
TOS.TO: 2.23 (-0.02)
TSO3 Reports Third Quarter 2015 Financial Results
PR Newswire - Wed Nov 04, 6:00AM CST
Q3 Revenues Ramp to $1.2 Million, Driven by U.S. Commercial Rollout of STERIZONE® VP4 Sterilizer Build-Out of U.S. Distribution and Customer Support Facility Complete
TOS.TO: 2.23 (-0.02)
TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
PR Newswire - Mon Oct 26, 7:30AM CDT
STERIZONE® VP4 Sterilizer Achieves Industry First: Terminally Sterilize up to Eight Channels in a Single Device
TOS.TO: 2.23 (-0.02)
TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update
PR Newswire - Wed Jun 01, 4:00PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to a previously announced request for additional information by the U.S. Food and Drug Administration (the FDA) and that it has substantially completed its improvements to its manufacturing facility in Québec.
TOS.TO: 2.23 (-0.02)
Canadian Journal of Infection Control to Publish Paper on TSO3's STERIZONE® VP4 Sterilizer
PR Newswire - Wed May 18, 1:36PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that a peer-reviewed paper describing the Company's STERIZONE® VP4 Sterilizer has been accepted for publication in the Canadian Journal of Infection Control (CJIC). The paper entitled "The First Dual-Sterilant Low-Temperature Sterilization System" will appear in an upcoming issue of the publication.
TOS.TO: 2.23 (-0.02)
TSO3 announces the Results of the Votes from its Annual and Special Meeting of the Shareholders
PR Newswire - Thu May 05, 3:02PM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated March 22, 2016, were elected as directors of TSO3 Inc. In addition, all other proposals submitted by management were approved.
TOS.TO: 2.23 (-0.02)
TSO3 Reports Record First Quarter 2016 Results
PR Newswire - Wed May 04, 5:30AM CDT
Commercial Rollout Drives Revenues of US$3.1 Million and Gross Profit of US$1.1 Million
TOS.TO: 2.23 (-0.02)
TSO3 to Report First Quarter 2016 Results and Hold Annual General and Special Meeting of Shareholders on Wednesday, May 4, 2016
PR Newswire - Tue Apr 26, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will report its first quarter 2016 financial results ended March 31, 2016 via press release on Wednesday, May 4, 2016 before the market opens.
TOS.TO: 2.23 (-0.02)
TSO3 to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2016
PR Newswire - Mon Apr 18, 6:30AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at Bloom Burton & Co. Healthcare Investor Conference being held on May 2-3, 2016 at the Sheraton Centre Toronto Hotel in Toronto, Ontario.
TOS.TO: 2.23 (-0.02)
TSO3 Receives FDA 510(k) Clearance for Universal Design of STERIZONE® VP4 Sterilizer
PR Newswire - Mon Mar 28, 6:00AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a universal design of its STERIZONE® VP4 Sterilizer.
TOS.TO: 2.23 (-0.02)
TSO3 Reports Fourth Quarter and Full Year 2015 Results
PR Newswire - Wed Mar 23, 6:00AM CDT
Orders Received in 2015 Drive 2016 Commercial Rollout of STERIZONE® VP4 Sterilizer
TOS.TO: 2.23 (-0.02)
TSO3 Provides Update on Extended U.S. Claims Filed for Breakthrough Medical Device Sterilizer
PR Newswire - Mon Mar 14, 6:00AM CDT
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has received feedback from the U.S. regulators regarding the company's recent application to extend claims for the STERIZONE® VP4 Sterilizer.
TOS.TO: 2.23 (-0.02)
TSO3 to Present at the 28th Annual ROTH Conference on March 16, 2016
PR Newswire - Thu Mar 10, 6:30AM CST
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at the 28th Annual ROTH Capital Partners Conference, which is being held on March 14-16, 2016 at The Ritz-Carlton, Laguna Niguel in Dana Point, California.
TOS.TO: 2.23 (-0.02)
TSO3 Appoints Harold R. Tessman as COO
PR Newswire - Wed Jan 27, 5:30AM CST
TSO3 Inc. (TSX: TOS), a leader in low-temperature medical device sterilization, has appointed Harold R. Tessman to the new position of chief operating officer.
TOS.TO: 2.23 (-0.02)
TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
PR Newswire - Tue Dec 22, 6:00AM CST
Company Submits Required Documentation Seeking Clearance to Extend Sterilization Claims to Include up to Eight Channels in a Single Device for its STERIZONE® VP4 Sterilizer - an Industry First
TOS.TO: 2.23 (-0.02)
TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
PR Newswire - Mon Dec 21, 3:37PM CST
Company Notifies Suppliers and Accelerates Workforce Recruitment in Canada and the United States
TOS.TO: 2.23 (-0.02)
TSO3 Appoints Glen Kayll as Chief Financial Officer
PR Newswire - Fri Dec 18, 6:00AM CST
Seasoned Public Company CFO With Financial and Cross Border Listing Experience to Join Management Team
TOS.TO: 2.23 (-0.02)
TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
PR Newswire - Thu Dec 17, 6:00AM CST
STERIZONE® VP4 Sterilizer Validated to Sterilize Complex, Multi-Channel Endoscopic Devices
TOS.TO: 2.23 (-0.02)
TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
PR Newswire - Wed Nov 25, 10:40AM CST
US$7.5 Million Up-Front License Fees and Performance Minimums Highlights of Agreement
TOS.TO: 2.23 (-0.02)
IIROC Trade Halt - TSO3 Inc.
Newsfile Corp - Wed Nov 25, 8:36AM CST
The following issues have been halted by IIROC:
TSO3 Appoints Steve West to Board of Directors
PR Newswire - Tue Nov 10, 9:14AM CST
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has appointed Steve West to the Company's board of directors.
TOS.TO: 2.23 (-0.02)
TSO3 Reports Third Quarter 2015 Financial Results
PR Newswire - Wed Nov 04, 6:00AM CST
Q3 Revenues Ramp to $1.2 Million, Driven by U.S. Commercial Rollout of STERIZONE® VP4 Sterilizer Build-Out of U.S. Distribution and Customer Support Facility Complete
TOS.TO: 2.23 (-0.02)
TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
PR Newswire - Mon Oct 26, 7:30AM CDT
STERIZONE® VP4 Sterilizer Achieves Industry First: Terminally Sterilize up to Eight Channels in a Single Device
TOS.TO: 2.23 (-0.02)
